Inventor · disambiguated record
Gabriel Wauer
Also filed as: WAUER GABRIEL
9 granted patents·18 pending applications·12 citations·filing 2012–2021
79Inventor score
Top patents by PatentIndex Score
27 records- 0187US9549903B2Transdermal delivery system comprising buprenorphinePURDUE PHARMA LP·Filed 2016·Granted Jan 24, 2017·11 cites·28 claims
- 0267US11529345B2Buprenorphine transdermal delivery systemLTS LOHMANN THERAPIE SYSTEME AG·Filed 2020·Granted Dec 20, 2022·0 cites·48 claims
- 0367US10335377B2Over-patch having improved compatibility and a long adhesion duration and method for producing said over-patchLTS LOHMANN THERAPIE SYSTEME AG·Filed 2015·Granted Jul 2, 2019·1 cites·15 claims
- 0467US2020316055A1Transdermal delivery systemLTS LOHMANN THERAPIE SYSTEME AG·Filed 2020·Application pending·0 cites
- 0561US2020306204A1Transdermal delivery system comprising buprenorphineLTS LOHMANN THERAPIE SYSTEME AG·Filed 2020·Application pending·0 cites
- 0659US11583505B2Over-patch having improved compatibility and a long adhesion duration and method for producing said over-patchLTS LOHMANN THERAPIE SYSTEME AG·Filed 2019·Granted Feb 21, 2023·0 cites·11 claims
- 0759US2020253957A1Transdermal delivery systemLTS LOHMANN THERAPIE SYSTEME AG·Filed 2020·Application pending·0 cites
- 0859US2016008294A1Transdermal delivery systemPURDUE PHARMA LP·Filed 2014·Application pending·0 cites
- 0958US12285488B2Oral dosage form containing theobromine-free cocoaLTS LOHMANN THERAPIE SYSTEME AG·Filed 2018·Granted Apr 29, 2025·0 cites·14 claims
- 1058US2018092905A1Transdermal delivery systemPURDUE PHARMA LP·Filed 2017·Application pending·0 cites
- 1155US2017128384A1Buprenorphine transdermal delivery systemPURDUE PHARMA LP·Filed 2017·Application pending·0 cites
- 1253US12121616B2Transdermal therapeutic system for the transdermal administration of solifenacinLTS LOHMANN THERAPIE SYSTEME AG·Filed 2019·Granted Oct 22, 2024·0 cites·21 claims
- 1352US2014363487A1Transdermal delivery system comprising buprenorphinePURDUE PHARMA LP·Filed 2012·Application pending·0 cites
- 1452US2016101100A1Transdermal delivery systemPURDUE PHARMA LP·Filed 2015·Application pending·0 cites
- 1551US2015306093A1Transdermal delivery systemPURDUE PHARMA LP·Filed 2013·Application pending·0 cites
- 1650US12397142B2Microneedle array having an active ingredient in the form of saltsLTS LOHMANN THERAPIE SYSTEME AG·Filed 2018·Granted Aug 26, 2025·0 cites·15 claims
- 1750US2017049713A1Transdermal delivery system comprising buprenorphinePURDUE PHARMA LP·Filed 2016·Application pending·0 cites
- 1850US2018193333A1Transdermal delivery systemPURDUE PHARMA LP·Filed 2018·Application pending·0 cites
- 1949US12383509B2Transdermal delivery system including an emulsifierLTS LOHMANN THERAPIE SYSTEME AG·Filed 2018·Granted Aug 12, 2025·0 cites·11 claims
- 2049US11964060B2Nicotine-containing transparent transdermal therapeutic systemLTS LOHMANN THERAPIE SYSTEME AG·Filed 2018·Granted Apr 23, 2024·0 cites·20 claims
- 2149US2021000755A1Transdermal therapeutic system for the transdermal administration of buprenorphine comprising a silicone acrylic hybrid polymerLTS LOHMANN THERAPIE SYSTEME AG·Filed 2019·Application pending·0 cites
- 2249US2023218539A1Transdermal therapeutic system comprising the ingredient rotigotine and at least one non-amine-resistant silicone adhesiveLUYE PHARMA SWITZERLAND AG·Filed 2021·Application pending·0 cites
- 2343US2021008000A1Transdermal therapeutic system comprising a silicone acrylic hybrid polymerLTS LOHMANN THERAPIE SYSTEME AG·Filed 2019·Application pending·0 cites
- 2443US2021038532A1Transdermal therapeutic system comprising a silicone acrylic hybrid polymerLTS LOHMANN THERAPIE SYSTEME AG·Filed 2019·Application pending·0 cites
- 2543US2022241215A1Transdermal therapeutic system comprising an active agent-containing layer comprising a silicone-containing polymer and a skin contact layer comprising a silicone gel adhesiveLTS LOHMANN THERAPIE SYSTEME AG·Filed 2020·Application pending·0 cites
- 2637US2022241216A1Transdermal therapeutic system comprising an active agent-containing layer comprising an acrylic polymer and a skin contact layer comprising a silicone gel adhesiveLTS LOHMANN THERAPIE SYSTEME AG·Filed 2020·Application pending·0 cites
- 2736US2021000756A1Transdermal therapeutic system comprising a silicone acrylic hybrid polymerLTS LOHMANN THERAPIE SYSTEME AG·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Gabriel Wauer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →